Dunvegan Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $1.47M | Sell |
50,454
-1,100
| -2% | -$31.9K | 1.72% | 16 |
|
|
2015
Q3 | $1.4M | Sell |
51,554
-750
| -1% | -$20.3K | 1.59% | 19 |
|
|
2015
Q2 | $1.43M | Sell |
52,304
-15,700
| -23% | -$430K | 1.58% | 20 |
|
|
2015
Q1 | $1.82M | Sell |
68,004
-150
| -0.2% | -$4K | 1.61% | 21 |
|
|
2014
Q4 | $1.44M | Sell |
68,154
-1,082
| -2% | -$22.9K | 1.25% | 22 |
|
|
2014
Q3 | $1.65M | Buy |
69,236
+266
| +0.4% | +$6.34K | 1.49% | 21 |
|
|
2014
Q2 | $1.59M | Hold |
68,970
| – | – | 1.33% | 23 |
|
|
2014
Q1 | $1.57M | Sell |
68,970
-59,460
| -46% | -$1.36M | 1.32% | 27 |
|
|
2013
Q4 | $2.37M | Sell |
128,430
-6,050
| -4% | -$112K | 1.96% | 17 |
|
|
2013
Q3 | $2.28M | Sell |
134,480
-3,710
| -3% | -$62.8K | 1.68% | 23 |
|
|
2013
Q2 | $2.14M | Buy |
+138,190
| New | +$2.14M | 1.65% | 22 |
|